IDO+ DCs had ≅65% higher percentage in ELTGF patients versus controls and CGD (P < 0.001), whilst CGD had ≅40% lower levels of IDO-circulating cells versus controls (P = 0.003; Figures 4(f)–4(j) and 4(m), Table 2). The gene discussed is IDO1; the disease is chronic granulomatous disease.